Drug Safety Evaluation - WIL Research Europe
WIL research Europe is based in the Netherlands and specializes in personalized contract research and expert consultancy for the non-clinical development and registration of pharmaceutical products worldwide. Together we employ more than 1200 well trained and dedicated specialists. With laboratories in both Europe and United States we are able to provide your company the global footprint that it needs.
With a focus on regulatory preclinical development, our non-clinical support covers drug development from lead selection to marketing authorisation, from ADME, toxicology and safety pharmacology to reproduction toxicity and environmental risk assessment.
Furthermore, NOTOX experts are experienced in design and performance of dedicated development programs which are compound specific (e.g. NCE's, NBE's, vaccines and biosimilars), disease specific (e.g. anticancer), population specific (e.g. juvenile toxicity studies to support paediatric trials) and purpose specific (e.g. non-clinical support for exploratory clinical trials).
For more information please contact us directly or visit our company website: